Synthetic Biology Market worth $5,630.4 Million by 2018 Synthetic Biology Market

Synthetic Biology Market worth $5,630.4 Million by 2018
The report “Synthetic Biology Market by Tool(XNA, Chassis, Oligos, Enzymes, Cloning kits), By
Technology (Bioinformatics, Nanotechnology, Gene Synthesis, Cloning & Sequencing), By Application
(Biofuels, Pharmaceuticals, Biomaterials, Bioremediation) - Global Forecast to 2018”, analyzes and
studies the major market drivers, threats, opportunities, and challenges.
Browse 99 market data tables and 46 figures spread through 185 pages and in-depth TOC on "Synthetic
Biology Market by Tool(XNA, Chassis, Oligos, Enzymes, Cloning kits), By Technology (Bioinformatics,
Nanotechnology, Gene Synthesis, Cloning & Sequencing), By Application (Biofuels, Pharmaceuticals,
Biomaterials, Bioremediation) - Global Forecast to 2018"

http://www.marketsandmarkets.com/Market-Reports/synthetic-biology-market-889.html

This report studies the global synthetic biology market for the forecast period of 2013 to 2018. This
market is expected to reach $5,630.4 million by 2018 from $1,923.1 million in 2013, growing at a CAGR
of 24% during the forecast period.
The global synthetic biology market is segmented on the basis of tools, technologies, applications, and
geographies.
On the basis of tools, the synthetic biology market is categorized into Xeno-nucleic acids, chassis
organisms, oligonucleotides, enzymes, and cloning and assembly kits. The oligonucleotides segment
accounted for a major share of the synthetic biology market, by tool, in 2013.
On the basis of technologies, the synthetic biology market is segmented into enabled and enabling
technologies. Enabling technologies accounted for a major share of the synthetic biology market in 2013.
On the basis of applications, the synthetic biology market is segmented into environmental, medical, and
industrial applications. The medical applications segment accounted for a major share of the synthetic
biology market in 2013.
On the basis of regions, the market is divided into North America, Europe, Asia, and Rest of the World
(RoW). The Rest of the World region comprises Latin America, Pacific countries, and Middle East and
Africa. North America accounted for the largest share of the synthetic biology market, followed by Europe
and Asia. However, the European market is expected to grow at the highest CAGR in the coming five
years, and serves as a revenue pocket for the companies involved in the manufacturing of synthetic
biology products.
Over the years, the demand for synthetic biology is likely to increase owing to the increasing R&D
expenditure in pharmaceutical and biotechnology companies, growing demand for synthetic genes, rising
production of genetically modified crops, and incessantly rising funding in the field of synthetic biology.
However, ethical and social issues such as biosafety and biosecurity are major factors that are restricting
the growth of this market. Furthermore, rising concerns over fuel consumption and increasing demand for
protein therapeutics are likely to create opportunities for the synthetic biology market. However,
standardization and integration of biological parts at system-level still remains a challenge for this market.
Some of the major players in the global synthetic biology market include Amyris, Inc. (U.S.), DuPont
(U.S.), GenScript USA, Inc. (U.S.), Intrexon Corporation (U.S.), Integrated DNA Technologies (IDT)